肾脏累及的弥漫性大B细胞淋巴瘤患者临床病理特征
|
|
王博恩, 陈思远, 施晴, 张慕晨, 易红梅, 董磊, 王黎, 程澍, 许彭鹏, 赵维莅
|
Clinicopathologic characteristics of patients with kidney-involved diffuse large B-cell lymphoma
|
|
WANG Boen, CHEN Siyuan, SHI Qing, ZHANG Muchen, YI Hongmei, DONG Lei, WANG Li, CHENG Shu, XU Pengpeng, ZHAO Weili
|
|
表1 肾脏累及的DLBCL患者临床特征分析［n（%）， N=149］
|
Tab 1 Analysis of clinical characteristics of patients with kidney-involved DLBCL ［n（%）， N=149］
|
|
| Chatacteristic | n (%) |
|---|
| Age of diagnose | | | ≤60/years | 62 (41.6) | | >60/years | 87 (58.4) | | Ann Arbor stage | | | Ⅰ‒Ⅱ | 28 (18.8) | | Ⅲ‒Ⅳ | 121 (81.2) | | ECOG | | | 0‒1 score | 122 (81.9) | | ≥2 score | 27 (18.1) | | Serum LDH | | | Normal | 28 (18.8) | | Elevated | 121 (81.2) | | Extranodal involvement | | | 0‒1 | 38 (25.5) | | ≥2 | 111 (74.5) | | IPI | | | 0‒1 score | 18 (12.1) | | 2‒5 score | 131 (87.9) | | Pathological subtype | | | DLBCL, NOS | 145 (97.3) | | HGBCL with MYC and BCL2/BCL6 rearrangement | 4 (2.7) | | Hans classification | | | GCB | 39 (26.2) | | non-GCB | 90 (60.4) | | Unknown | 20 (13.4) | | MYC and BCL2 double expressor | | | Yes | 36 (24.2) | | No | 113 (75.8) | | Outcome① | | | CR | 87 (60.4) | | PR | 11 (7.6) | | SD/PD | 46 (31.9) | | Unknown | 5 (3.4) |
|
|
|